Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > 15$ ZACKS valuation just a starter

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Oct 11, 2021 11:00pm

92 Views

Post# 33996118

RE:RE:15$ ZACKS valuation just a starter

golddetector, ANOHER\

DUMMY

do you REALLY belive a stock that has already failed adn rolled back, has postive results" on 10 rats (lol). some patents in INDIA (ROFlOL), and a deal with a penny stock heading towards zero. with the "deal" meaning they get pennies on the sales, unti it hits zero...in any possible way mean sLExX is heading to $75??????. they are spending like CRAZY on stock promotion.....why is that?

IF you BELIVE it is heading to $75, and you do not know WHY they are spening like crazy on STOCK PROMOTION...you are a noob, anf wil lose

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market